Clinical trials: Bile Acid Malabsorption
Irritable Bowel Syndrome With Diarrhea
Eluxadoline Bile Acid Malabsorption (BAM) Study
This study will evaluate the possibility of a differential effect of eluxadoline on altered bowel function in Irritable Bowel Syndrome with Diarrhea (IBS-D) participants with and without evidence of Bile Acid Malabsorption (BAM).
- Trial name
- NCT03441581
- Testing
- Eluxadoline
- Where
- United States
- Volunteers
- 24 people
- Sponsor
- Allergan
Primary Bile Acid Diarrhea
To Assess Safety, Tolerability and Efficacy of LJN452 in Patients With Primary Bile Acid Diarrhea.
The purpose of this study is to determine whether LJN452 improves the symptoms of bile acid diarrhea and to assess its safety and tolerability profile in patients with primary bile acid diarrhea (pBAD) to guide decision-making…
- Trial name
- NCT02713243
- Testing
- LJN452
- Where
- 4 sites in United States, United Kingdom
- Volunteers
- 20 people
- Sponsor
- Novartis Pharmaceuticals
Bile Acid Malabsorption
Double-blind, Randomised Study of A3384 in BAM/BAD
The purpose of this trial is to determine the efficacy and safety of A3384 administered to patients with Bile Acid Malabsorption (BAM)/Bile Acid Diarrhoea (BAD).
- Trial name
- NCT02078856
- Testing
- A3384
- Where
- 3 sites in Sweden, United Kingdom
- Volunteers
- 19 people
- Sponsor
- Albireo